文献速递神经肿瘤

小范围扩大双额入路治疗中线前颅底脑膜瘤:连续54例患者经验

Small Extended Bifrontal Approach for Midline Anterior Skull Base Meningiomas: Our Experience with 54 Consecutive Patients.
PubMed 文献 · World Neurosurg · 2019-01-11

本研究描述小范围扩大双额入路技术并回顾54例中线前颅底脑膜瘤患者的临床结局,全部实现全切除,无死亡,平均随访39.5个月无复发,作者认为该技术安全有效且入路相关并发症较少。

要点

  • 小范围扩大双额入路行中线前颅底脑膜瘤全切除,54例均实现全切除。
  • 嗅沟脑膜瘤29例中12例术前嗅觉正常,术后8例嗅觉保留。
  • TSMs/PSMs 25例中23例术前视力受损,术后13例改善、8例不变、2例恶化。

核心结论

  • 小范围扩大双额入路是切除中线前颅底脑膜瘤的安全有效技术,提供充分手术暴露且入路相关并发症较少。
  • 对于偏好双额入路及其扩大变体的外科医生,该入路是极好的替代选择。

研究设计与样本

  • 前瞻性获取数据库的回顾性分析,连续纳入54例接受小范围扩大双额开颅术的中线前颅底脑膜瘤患者。
  • 小范围扩大双额开颅术向下延伸至鼻额缝而不进入眶,向上至眶上缘上方3 cm,向两侧至中线旁开3 cm。

主要发现

  • 54例中嗅沟脑膜瘤29例、蝶骨平台脑膜瘤2例、鞍结节脑膜瘤23例,全部实现全切除。
  • 29例嗅沟脑膜瘤中12例(41.4%)术前嗅觉正常,术后8例嗅觉保留。
  • 25例鞍结节/蝶骨平台脑膜瘤中23例(92.0%)术前视力受损,术后13例(56.5%)视力改善、8例(34.8%)不变、2例(8.7%)恶化。
  • 鞍结节/蝶骨平台脑膜瘤患者最常见并发症为嗅觉丧失5例(20.0%)和嗅觉减退3例(12.0%)。
  • 无死亡病例,平均随访39.5个月(范围16-64个月)期间所有患者均无复发。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the technique of a small extended bifrontal approach and review the clinical outcome of patients with midline anterior skull base (MASB) meningiomas treated using this technique. METHODS: The small extended bifrontal craniotomy extends inferiorly to the nasofrontal suture without entering the orbit, superiorly 3 cm above the supraorbital rim, and laterally 3 cm to the midline on both sides. A review of a prospectively acquired database was performed of 54 consecutive patients with MASB meningiomas who underwent this craniotomy. RESULTS: Twenty-nine patients with olfactory groove meningiomas, 2 with planum sphenoidale meningiomas (PSMs), and 23 with tuberculum sellae meningiomas (TSMs) were treated using this technique. Gross total resection was achieved in all patients. Of 29 patients with olfactory groove meningiomas, 12 (41.4%) had normal olfaction at presentation and 8 had preservation of olfaction postoperatively. Of 25 patients with TSMs/PSMs, 23 (92.0%) had preoperative visual impairment, with 13 showing improved vision (56.5%), 8 unchanging (34.8%), and 2 deteriorating (8.7%) after surgery. The most common complications were anosmia and hyposmia, which occurred in 5 patients (20.0%) and 3 patients (12.0%) with TSMs/PSMs, respectively. No mortality was reported. There was no recurrence in all patients after a mean follow-up of 39.5 months (range, 16-64 months). CONCLUSIONS: The small extended bifrontal approach is a safe and effective technique for resection of MASB meningiomas, which provides adequate surgical exposure with less approach-related morbidity. It is an excellent alternative for surgeons who favor the bifrontal approach and its extended variations.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Xu M, Xu J, Huang X, et al. Small Extended Bifrontal Approach for Midline Anterior Skull Base Meningiomas: Our Experience with 54 Consecutive Patients. World Neurosurg. 2019. PMID: 30639482. doi:10.1016/j.wneu.2018.12.172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。